<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Paper And Industrial essayChange</title>
	<atom:link href="http://www.perilip.org/tag/change/feed" rel="self" type="application/rss+xml" />
	<link>http://www.perilip.org</link>
	<description>About  paper and industrial essay Share ideas</description>
	<lastBuildDate>Sat, 09 Jan 2010 19:11:24 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>Managing Innovation and Change: Case of Pharmaceutical Industry</title>
		<link>http://www.perilip.org/managing-innovation-and-change-case-of-pharmaceutical-industry</link>
		<comments>http://www.perilip.org/managing-innovation-and-change-case-of-pharmaceutical-industry#comments</comments>
		<pubDate>Wed, 02 Dec 2009 11:02:59 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Case]]></category>
		<category><![CDATA[Change]]></category>
		<category><![CDATA[Industry]]></category>
		<category><![CDATA[Innovation]]></category>
		<category><![CDATA[Managing]]></category>
		<category><![CDATA[Pharmaceutical]]></category>

		<guid isPermaLink="false">http://www.perilip.org/managing-innovation-and-change-case-of-pharmaceutical-industry</guid>
		<description><![CDATA[<p>In contemporary context, the pharmaceutical and biotechnology sectors are characterised by a high level of competition and innovation. Some fifteen or twenty years ago biotechnology, which was heavily depended on advances in molecular biology, and pharmaceuticals, which was predominantly based on microbiology and chemistry, were widely recognized as separate industries. However, now biotechnology and pharmaceutical companies are significantly interconnected and are evolving into complex systems, representing particular innovation networks.
The transformation from an old to a new <a href='http://www.perilip.org/managing-innovation-and-change-case-of-pharmaceutical-industry' rel="nofollow">Read more</a></p>Here is no comments yet by the time your rss reader get this, Do you want to be the first commentor? Hurry up]]></description>
			<content:encoded><![CDATA[<p>In contemporary context, the pharmaceutical and biotechnology sectors are characterised by a high level of competition and innovation. Some fifteen or twenty years ago biotechnology, which was heavily depended on advances in molecular biology, and pharmaceuticals, which was predominantly based on microbiology and chemistry, were widely recognized as separate industries. However, now biotechnology and pharmaceutical companies are significantly interconnected and are evolving into complex systems, representing particular innovation networks.
The transformation from an old to a new <a href='http://www.perilip.org/managing-innovation-and-change-case-of-pharmaceutical-industry' rel="nofollow">Read more</a></p>Here is no comments yet by the time  your rss reader get this, Do you want to be the first commentor? Hurry up ]]></content:encoded>
			<wfw:commentRss>http://www.perilip.org/managing-innovation-and-change-case-of-pharmaceutical-industry/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Innovation and Change in Pharmaceutical Industry</title>
		<link>http://www.perilip.org/innovation-and-change-in-pharmaceutical-industry</link>
		<comments>http://www.perilip.org/innovation-and-change-in-pharmaceutical-industry#comments</comments>
		<pubDate>Wed, 02 Dec 2009 09:32:55 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Change]]></category>
		<category><![CDATA[Industry]]></category>
		<category><![CDATA[Innovation]]></category>
		<category><![CDATA[Pharmaceutical]]></category>

		<guid isPermaLink="false">http://www.perilip.org/innovation-and-change-in-pharmaceutical-industry</guid>
		<description><![CDATA[<p>Achilladelis and Antonakis conducted a historical study of the dynamics and tendencies of technological innovation in the pharmaceutical industry. From this standpoint, pursuing increase in market share, major pharma companies undertake mergers and acquisitions. As the majority of specialists points out, particularly mergers and acquisitions are considered to be essential ways to obtain innovation capabilities and assuming control levers of any major technological changes within biotech industry. For instance, in the beginning of 90s, Swiss pharmaceutical giant Hoffmann-La Roche after <a href='http://www.perilip.org/innovation-and-change-in-pharmaceutical-industry' rel="nofollow">Read more</a></p>Here is no comments yet by the time your rss reader get this, Do you want to be the first commentor? Hurry up]]></description>
			<content:encoded><![CDATA[<p>Achilladelis and Antonakis conducted a historical study of the dynamics and tendencies of technological innovation in the pharmaceutical industry. From this standpoint, pursuing increase in market share, major pharma companies undertake mergers and acquisitions. As the majority of specialists points out, particularly mergers and acquisitions are considered to be essential ways to obtain innovation capabilities and assuming control levers of any major technological changes within biotech industry. For instance, in the beginning of 90s, Swiss pharmaceutical giant Hoffmann-La Roche after <a href='http://www.perilip.org/innovation-and-change-in-pharmaceutical-industry' rel="nofollow">Read more</a></p>Here is no comments yet by the time  your rss reader get this, Do you want to be the first commentor? Hurry up ]]></content:encoded>
			<wfw:commentRss>http://www.perilip.org/innovation-and-change-in-pharmaceutical-industry/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

